ArticleRespiratory research2026
Spatial heterogeneity in the burden of respiratory syncytial virus infection attributable to low and high ambient temperature in Japan: a nationwide time-stratified case-crossover analysis.
Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Respiratory syncytial virus (RSV) infection poses a considerable disease burden worldwide. Although multiple studies have estimated the short-term effects of ambient temperature on mortality and morbidity, the burden of RSV attributable to temperature is poorly characterized. This nationwide study aimed to quantify the total burden of RSV infection in Japan attributable to non-optimum ambient temperature conditions, and to partition this burden into contributions from low and high temperatures and from moderate and extreme components of non-optimum temperature. We collected weekly time-series data on the number of reported RSV cases and meteorological variables (mean temperature, relative humidity, wind speed, and sunshine duration) for all 47 Japanese prefectures from 2006 to 2019. An extended two-stage approach was used: First, a time-stratified case-crossover design fitted with conditional quasi-Poisson regression was used to estimate prefecture-specific associations. Second, multivariate random-effects meta-analysis was used to obtain pooled estimates. The number of attributable cases were estimated for temperatures above and below the optimum minimum morbidity temperature (MMT) and further categorized as moderate or extreme using the 2.5th and 97.5th percentiles as cutpoints. Data on 1,227,012 RSV cases reported during the study period were analyzed. The pooled exposure-response relationship between temperature and RSV incidence was U-shaped, with a higher RSV incidence at both low and high temperature levels. In most prefectures the MMT was between the 40th to 50th percentiles of the local temperature distribution. Overall, 21.32% (95% empirical confidence interval [eCI] 18.93% to 22.78%) of cases were attributable to non-optimum temperature, with marked geographic heterogeneity: from 8.24% (95% eCI: - 9.06-21.12%) in Akita, to 32.63% (95% eCI: 27.86-41.78%) in Kagoshima. A greater share of temperature-attributable cases was due to moderate high temperatures (12.27%, 95% eCI: 10.95-13.19%) than to low temperatures (9.05%, 95% eCI: 7.12-10.36%), whereas the contributions of extremely high and extremely low temperatures were relatively small. High weekly mean ambient temperatures over lag 0-3 weeks were associated with a substantial attributable risk of RSV infection. Public health efforts to reduce the RSV burden should take ambient temperature into account, paying particular attention to the impact of sustained, moderately warm conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.